Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
NCT01341119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2012-08-07
Summary
To study clinical features, prognostic factors and treatment outcome and to develop a possible prognostic index in skin/soft tissue primary NK/T cell lymphoma patients.
Conditions
- Extranodal NK/T Cell Lymphoma
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Won Seog Kim, MD, PhD · Samsung Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea
NCT04048395 ·Status: UNKNOWN
-
Gemcitabine in NK/T Cell Lymphoma
NCT01660568 ·Status: COMPLETED
-
A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type
NCT02927925 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
NCT01802138 ·Status: COMPLETED ·Phase: NA
-
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
NCT02445404 ·Status: UNKNOWN ·Phase: PHASE2
-
Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
NCT00846157 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
NCT01676558 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
NCT03117036 ·Status: RECRUITING
-
Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
NCT01965119 ·Status: COMPLETED ·Phase: PHASE2
-
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
NCT05618925 ·Status: RECRUITING ·Phase: PHASE1
-
The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)
NCT01266668 ·Status: COMPLETED
-
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
NCT05821192 ·Status: UNKNOWN ·Phase: NA
-
Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma
NCT07125872 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
NCT04414163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
NCT03021057 ·Status: UNKNOWN ·Phase: PHASE2
-
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
NCT04061850 ·Status: COMPLETED
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
NCT05518851 ·Status: RECRUITING
-
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149 ·Status: RECRUITING
-
Cohort of Peripheral T Cell Lymphoma
NCT02364466 ·Status: UNKNOWN
-
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL
NCT03971318 ·Status: UNKNOWN
-
Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
NCT02474550 ·Status: UNKNOWN
-
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
NCT07032103 ·Status: RECRUITING
-
Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
NCT03790891 ·Status: UNKNOWN ·Phase: EARLY_PHASE1